• Wed. Nov 29th, 2023

Health Administration

Come One, Come All To Health Administration

drug

  • Home
  • Biden-Harris Administration Proposes to Protect People with Medicare Advantage and Prescription Drug Coverage from Predatory Marketing, Promote Healthy Competition, and Increase Access to Behavioral Health Care in the Medicare Advantage Program

Biden-Harris Administration Proposes to Protect People with Medicare Advantage and Prescription Drug Coverage from Predatory Marketing, Promote Healthy Competition, and Increase Access to Behavioral Health Care in the Medicare Advantage Program

Today, the Biden-Harris Administration is proposing important steps to strengthen Medicare Advantage and the Medicare Prescription Drug Benefit Program (Part D). As part of his Bidenomics agenda, President Biden has…

Bicycle Health Commends U.S. Drug Enforcement Administration as It Extends Telemedicine Rule Through the End of 2024

Bicycle Health This decision will continue to protect thousands of patients across the U.S. who access care for opioid use disorder via clinically proven virtual care platforms BOSTON, Oct. 06,…

Health officials are recommending the Drug Enforcement Administration lower the restrictions around cannabis

WASHINGTON (Gray DC) – “What we’ve created is a very significant amount of conflict between the federal government’s position on cannabis and where the states have evolved and developed,” said…

Addressing the Rising Need for Hazardous Drug Safety in Healthcare Settings

PRESS RELEASE Published July 19, 2023 Closed System Transfer Devices (CSTDs) are specialized medical devices designed to ensure safe and contamination-free transfer of hazardous medications, particularly in healthcare settings. These…

Bernie Sanders to block all Biden health nominees until admin delivers plan to lower drug prices: Report

Progressive Sen. Bernie Sanders, I-Vt., says he will oppose President Biden’s nominee to lead the National Institutes of Health (NIH), and any other health nominations, until the administration delivers its…

Belief: Why will never Medicare address the new Alzheimer’s drug?

The Heart for Medicaid and Medicare Products and services and its chief administrator, Chiquita Brooks-LaSure, appear increasingly isolated about Alzheimer’s drug lecanemab right after their counterparts at the Veterans Wellness…